Hexagon Bio

Hexagon Bio Closes $47 Million in Series A Financing to Advance Novel Oncology and Infectious Disease Therapies

Tue, Sep 15, 2020

The company is building a first-of-its-kind proprietary genomics database to reveal new secondary metabolites to combat human disease.

This Biotech Startup Just Raised $47 Million To Make Drugs From Fungi

Tue, Sep 15, 2020

Forbes

On September 15th, the company announced that it raised a $47 million Series A round that will help it genetically sequence fungi and find new breakthrough medications.

View article →

10 Start-Ups to Watch 2018

Mon, Nov 5, 2018

Chemical & Engineering News

C&EN’s writers and editors selected the finalists on the strength of their groundbreaking chemistry from nominations that readers and advisers sent from far and wide.

View article →

This Fungus Could Help Cure Cancer

Mon, Jun 4, 2018

Bloomberg Businessweek

Scientists are mining the DNA-sequence data from mushrooms and mold to find new drugs.

View article →

Hard-to-get fungal natural products found

Mon, Apr 16, 2018

Chemical & Engineering News

Technique produces compounds made naturally by tough-to-culture fungi or poorly expressed genes.

View article →

HEx Technology Cracks Cryptic Codes Identifying Potential Therapeutic Compounds

Wed, Apr 11, 2018

Technology Networks

Researchers have developed a technology, known as ‘HEx’, that can detect natural products from fungal species – products which are usually extremely difficult to identify. This approach could be used to find natural compounds with therapeutic potential, paving the way to novel antimicrobial drugs.

View article →

Scanning Fungal Warscapes for Drug Candidates

Tue, Oct 31, 2017

Genetic Engineering & Biotechnology News

Hexagon Bio leverages expertise in genomics, synthetic biology, chemistry, and computation to identify small molecules produced by fungi. These molecules, which are of intense interest to drug developers, might otherwise remain hidden.

View article →